Table 1 Clinical and demographic characteristics of HIV subjects in study cohorts

Age (years)*

45 (42–50)

45 (43–50)

Gender (male)

12 (60%)

15 (83%)

Race (African American)

15 (75%)

9 (50%)

BMI

23.7 (22.9-24.7)

23.9 (22.7-27.2)

HCV seropositive

7 (41%)

15 (100%)

Time on ART (months)*

30 (13–50)

36 (16–50)

CD4 T-cell count (cells/ul)*

267 (107–399)

213 (126–293)

Nadir CD4 T-cell count (cells/ul)*

58 (18–136)

53 (9–132)

Plasma HIV RNA (copies/ml)*

69 (50–181)

50 (50–88)

Total Bilirubin (mg/dL)*

0.6 (0.4-0.9)

0.6 (0.4-0.9)

ALT (IU/L)*

31 (23–77)

27 (20–38)

AST (IU/L)*

36 (25–59)

33 (24–52)

Alkaline Phosphatase (IU/L)*

96 (81–128)

88 (80–128)

Albumin (g/dL)*

4.0 (3.7-4.5)

4.0 (3.7-4.4)